tiprankstipranks
Trending News
More News >
European Wax Center (EWCZ)
NASDAQ:EWCZ
US Market

European Wax Center (EWCZ) AI Stock Analysis

Compare
58 Followers

Top Page

EW

European Wax Center

(NASDAQ:EWCZ)

Rating:66Neutral
Price Target:
$6.00
▲(3.99%Upside)
European Wax Center displays solid financial performance with strong cash flow management and operational efficiency, making it a resilient investment. However, technical indicators show moderate strength, and the valuation suggests the stock may be overpriced. Mixed sentiment from the earnings call adds caution, but strategic initiatives could drive future growth.
Positive Factors
Financial Performance
Raising target price from $4.50 to $6 reflects higher estimates and a higher terminal multiple in the DCF, given underlying comps have stabilized and no more franchise store closures were announced.
Revenue Growth
System-wide sales increased 2% in 1Q, driven in part by demand pull-forward from 2Q due to a successful retail promotion.
Strategic Initiatives
New leadership is doing what they can to reignite comp growth and get better visibility into franchise-level store profitability, including retooling their marketing efforts to bring new customers into centers.
Negative Factors
Market Challenges
New guest acquisition could be tempered as the consumer environment is pressured and tariffs add uncertainty to the mix.
Store Closures
Shares are down (~15%) as the number of store closures in '25 will likely be more than previously expected.
Unit Growth
Closures to outweigh openings in '25, resulting in a ~4% decline in units.

European Wax Center (EWCZ) vs. SPDR S&P 500 ETF (SPY)

European Wax Center Business Overview & Revenue Model

Company DescriptionEuropean Wax Center, Inc. operates as the franchisor and operator of out-of-home waxing services in the United States. The company offers body and facial waxing services; and pre- and post-service products, including ingrown hair serums, exfoliating gels, brow shapers, and skin treatments. As of March 26, 2022, it had a portfolio of centers operating in 874 locations across 44 states, including 868 franchised centers and six corporate-owned centers. European Wax Center, Inc. was founded in 2004 and is headquartered in Plano, Texas.
How the Company Makes MoneyEuropean Wax Center primarily generates revenue through its franchised locations, where franchisees pay initial franchise fees and ongoing royalties based on their sales. Additionally, the company earns income from the sale of proprietary waxing products, which are used in their services and also available for purchase by customers. These products contribute to both in-store sales and online revenue. The company's earnings are further supported by strategic marketing partnerships and customer loyalty programs that enhance brand visibility and customer retention.

European Wax Center Earnings Call Summary

Earnings Call Date:May 14, 2025
(Q1-2025)
|
% Change Since: 45.71%|
Next Earnings Date:Sep 16, 2025
Earnings Call Sentiment Neutral
The earnings call presented a mixed sentiment with solid financial results and marketing improvements, but also highlighted challenges such as center closures, uncertain environments, and tariff impacts. The company is actively addressing these issues and leveraging new marketing strategies to drive growth.
Q1-2025 Updates
Positive Updates
Solid First Quarter Results
European Wax Center delivered $225.9 million in system-wide sales, 70 basis points of positive same-store sales growth, and $18.8 million in adjusted EBITDA.
Same-Store Sales Growth
Same-store sales grew by 70 basis points. Adjusting for the Easter shift, it was approximately flat, indicating stabilization.
Improved Marketing Efficiency
New technology has improved the efficiency of paid media dollars, lowering cost per acquisition and showing early signs of traction with new guests.
Strong Cash Flow and Balance Sheet
Net cash provided by operating activities was $12.7 million with a strong free cash flow profile, maintaining a healthy balance sheet and a net leverage ratio of 4.3x.
Negative Updates
Center Closures
European Wax Center closed a net total of 5 centers in Q1 and expects 40 to 60 closures for the year, indicating underperformance in certain locations.
Uncertain Consumer and Supply Chain Environment
Acknowledged uncertainties in the consumer backdrop and supply chain environment, impacting business operations and growth strategies.
Reduced Revenue from Retail and Wholesale
Total revenue decreased by approximately $400,000 or 90 basis points, primarily due to lower retail and wholesale product revenue.
Tariff Impact Concerns
Potential impact of increased tariffs on product costs, with a portion of medical supplies and components sourced from China and Europe.
Company Guidance
During the European Wax Center's First Quarter Fiscal 2025 Earnings Call, CEO Chris Morris reported system-wide sales of $225.9 million, reflecting a 2.1% increase from the previous year, alongside a 70 basis points increase in same-store sales. The company achieved an adjusted EBITDA of $18.8 million. The guidance for fiscal 2025 was reiterated, with expectations for system-wide sales between $940 million and $960 million and same-store sales growth ranging from flat to 2%. The call also highlighted strategic efforts to enhance marketing effectiveness, improve franchisee support, and optimize new center expansion, aiming to drive sales, improve four-wall profitability, and reignite unit growth by the end of 2026.

European Wax Center Financial Statement Overview

Summary
European Wax Center exhibits solid financial health with strong operational efficiency and cash flow management. Despite a lower net profit margin, the company maintains healthy revenue growth and effective leverage control. The balance sheet poses some stability concerns with low equity levels, yet cash flow metrics strongly support liquidity and operational sustainability.
Income Statement
75
Positive
European Wax Center shows a strong performance with a notable TTM (Trailing-Twelve-Months) gross profit margin of approximately 73.6% and consistent revenue growth over previous years. However, net profit margin is relatively low at about 4.4% for TTM, reflecting some profit retention challenges. The company has improved its EBIT margin to 21.8% in TTM, indicating efficient operating performance.
Balance Sheet
60
Neutral
The balance sheet reveals a moderate debt-to-equity ratio of 0.11 in TTM, showing effective leverage management. However, the equity ratio stands at approximately 9.9%, which is relatively low, indicating potential financial stability risks. Return on equity is at a satisfactory level of 13.5% in TTM, showcasing decent equity efficiency.
Cash Flow
80
Positive
The company demonstrates robust cash flow management with a strong free cash flow to net income ratio of 6.04 in TTM, indicating excellent cash generation relative to net income. The operating cash flow to net income ratio is also healthy at 6.16, underscoring solid operational cash efficiency. Free cash flow growth has been positive, contributing to overall financial resilience.
BreakdownTTMMar 2025Mar 2024Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue216.47M216.92M221.02M207.35M178.68M103.41M
Gross Profit159.40M159.60M158.39M148.12M131.84M67.90M
EBITDA61.53M62.64M65.44M4.28M45.03M16.36M
Net Income9.49M10.46M8.93M13.61M3.97M-39.77M
Balance Sheet
Total Assets713.79M707.07M734.12M716.03M613.44M606.90M
Cash, Cash Equivalents and Short-Term Investments58.33M49.73M52.73M44.22M43.30M36.72M
Total Debt7.70M380.82M380.39M380.47M178.23M265.40M
Total Liabilities615.28M615.48M619.11M585.73M272.20M288.88M
Stockholders Equity70.45M64.05M82.02M79.00M-3.53M-62.00M
Cash Flow
Free Cash Flow57.34M55.98M54.82M44.11M33.14M-35.45M
Operating Cash Flow58.49M56.51M55.60M44.35M41.35M1.40M
Investing Cash Flow-1.15M-386.00K-785.00K-245.00K-8.20M-36.84M
Financing Cash Flow-59.43M-59.15M-46.38M-36.62M-26.56M61.90M

European Wax Center Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.77
Price Trends
50DMA
4.73
Positive
100DMA
4.95
Positive
200DMA
5.80
Negative
Market Momentum
MACD
0.21
Positive
RSI
57.64
Neutral
STOCH
42.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EWCZ, the sentiment is Positive. The current price of 5.77 is above the 20-day moving average (MA) of 5.73, above the 50-day MA of 4.73, and below the 200-day MA of 5.80, indicating a neutral trend. The MACD of 0.21 indicates Positive momentum. The RSI at 57.64 is Neutral, neither overbought nor oversold. The STOCH value of 42.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EWCZ.

European Wax Center Risk Analysis

European Wax Center disclosed 68 risk factors in its most recent earnings report. European Wax Center reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

European Wax Center Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
$318.53M28.2611.85%-2.93%-17.72%
ACACU
66
Neutral
$151.93M16.369.68%1.48%2.56%-47.22%
NUNUS
62
Neutral
$381.96M-4.93%3.10%-11.85%-1080.00%
62
Neutral
$16.72B10.85-7.48%3.15%1.66%-24.52%
56
Neutral
$245.72M-70.44%-17.97%49.13%
54
Neutral
$2.68M1.82-1.68%-9.25%-109.49%
38
Underperform
$44.28M-180.03%-19.83%22.76%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
EWCZ
European Wax Center
5.77
-3.95
-40.64%
ACU
Acme United
40.08
5.86
17.12%
NUS
Nu Skin
8.09
-2.01
-19.90%
TANH
Tantech Holdings
2.00
-30.00
-93.75%
SKIN
Beauty Health
1.95
0.11
5.98%
GROV
Grove Collaborative Holdings
1.10
-0.62
-36.05%

European Wax Center Corporate Events

Executive/Board ChangesShareholder Meetings
European Wax Center Elects New Board Directors
Neutral
Jun 5, 2025

On June 3, 2025, European Wax Center, Inc. held its annual meeting of stockholders, where key proposals were voted upon. The stockholders elected directors Alexa Bartlett and Julia Hunter to the Board of Directors for a three-year term. Additionally, the selection of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the year ending January 3, 2026, was ratified.

The most recent analyst rating on (EWCZ) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on European Wax Center stock, see the EWCZ Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 27, 2025